1. Home
  2. AXL vs ALT Comparison

AXL vs ALT Comparison

Compare AXL & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXL
  • ALT
  • Stock Information
  • Founded
  • AXL 1994
  • ALT 1997
  • Country
  • AXL United States
  • ALT United States
  • Employees
  • AXL N/A
  • ALT N/A
  • Industry
  • AXL Auto Parts:O.E.M.
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AXL Consumer Discretionary
  • ALT Health Care
  • Exchange
  • AXL Nasdaq
  • ALT Nasdaq
  • Market Cap
  • AXL 487.5M
  • ALT 472.3M
  • IPO Year
  • AXL 1999
  • ALT N/A
  • Fundamental
  • Price
  • AXL $4.33
  • ALT $5.80
  • Analyst Decision
  • AXL Hold
  • ALT Strong Buy
  • Analyst Count
  • AXL 8
  • ALT 7
  • Target Price
  • AXL $6.38
  • ALT $21.00
  • AVG Volume (30 Days)
  • AXL 3.0M
  • ALT 2.0M
  • Earning Date
  • AXL 05-02-2025
  • ALT 05-13-2025
  • Dividend Yield
  • AXL N/A
  • ALT N/A
  • EPS Growth
  • AXL N/A
  • ALT N/A
  • EPS
  • AXL 0.18
  • ALT N/A
  • Revenue
  • AXL $5,929,300,000.00
  • ALT $20,000.00
  • Revenue This Year
  • AXL N/A
  • ALT N/A
  • Revenue Next Year
  • AXL $0.27
  • ALT N/A
  • P/E Ratio
  • AXL $24.62
  • ALT N/A
  • Revenue Growth
  • AXL N/A
  • ALT N/A
  • 52 Week Low
  • AXL $3.00
  • ALT $3.55
  • 52 Week High
  • AXL $7.98
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • AXL 64.56
  • ALT 60.47
  • Support Level
  • AXL $4.04
  • ALT $4.95
  • Resistance Level
  • AXL $4.42
  • ALT $6.05
  • Average True Range (ATR)
  • AXL 0.21
  • ALT 0.37
  • MACD
  • AXL 0.12
  • ALT 0.11
  • Stochastic Oscillator
  • AXL 92.21
  • ALT 85.17

About AXL American Axle & Manufacturing Holdings Inc.

American Axle & Mfg Holdings Inc is engaged in manufacturing, engineering, designing, and validation of driveline systems and related components and chassis modules for light trucks, SUVs, crossover vehicles, passenger cars, and commercial vehicles. The company's segment includes Driveline and Metal Forming. It generates maximum revenue from the Driveline segment.

About ALT Altimmune Inc.

Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.

Share on Social Networks: